Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.7281
-0.0440 (-5.70%)
At close: Jun 5, 2026, 4:00 PM EDT
0.7425
+0.0144 (1.98%)
After-hours: Jun 5, 2026, 7:59 PM EDT

Tenaya Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
158154124221134782
Market Cap Growth
119.70%24.62%-44.10%64.75%-82.83%-
Enterprise Value
87.2361.4973.14124.85-41.05544.88
Last Close Price
0.730.711.433.242.0118.95
PB Ratio
1.491.251.331.590.552.81
P/TBV Ratio
1.230.881.311.720.371.21
EV/EBITDA Ratio
----0.34-
EV/EBIT Ratio
----0.33-
EV/FCF Ratio
----0.33-
Debt / Equity Ratio
0.070.060.120.060.050.05
Net Debt / Equity Ratio
-0.67-0.73-0.51-0.66-0.70-0.85
Net Debt / EBITDA Ratio
0.901.060.450.751.443.37
Net Debt / FCF Ratio
1.101.300.520.891.372.74
Asset Turnover
0.0000000
Quick Ratio
5.456.513.854.607.6911.54
Current Ratio
5.756.844.224.917.9911.73
Return on Equity (ROE)
-72.35%-83.84%-95.69%-64.83%-47.39%-34.80%
Return on Assets (ROA)
-60.89%-69.95%-79.84%-58.38%-42.36%-31.49%
Return on Invested Capital (ROIC)
-187.26%-187.23%-195.54%-172.11%-167.47%-182.28%
Return on Capital Employed (ROCE)
-68.75%-79.28%-92.11%-65.19%-45.92%-33.43%
Buyback Yield / Dilution
-95.26%-80.34%-14.96%-64.61%-152.75%-1724.34%
Total Shareholder Return
-95.26%-80.34%-14.96%-64.61%-152.75%-1724.34%
SEC Filings: 10-K · 10-Q